However, prevention of retinal ischemia-reperfusion injury can be achieved by administering a direct renin inhibitor [67], ACE inhibitor [65], AT1-R antagonist [65,69], or MR antagonist [68]. Here, NR3C2 is linked to retinal ischemia.